Telehealth's positive impact on health outcomes in the treatment of diabetes will be discussed in a presentation by Gail Nunlee-Bland, MD, Director and Chief of Endocrinology, Diabetes Treatment Center, Howard University Hospital at the Diabetes Centers of Excellence Conference.
Matthew Stanton, Head of RNA Optimization at Merck will give a featured presentation at the 3rd RNAi Research and Therapeutics Conference (May 30-31, 2012 in Boston, MA).
In response to rapid expansion, Peak Scientific broke first ground on a development which will extend their Head Office facility in Inchinnan, Scotland.
John Quackenbush, Director of the Center for Cancer Computational Biology, Dana-Farber Cancer Institute to give featured presentation entitled "The Road to Genomic Medicine is Paved with Data" at the 2nd Next Generation Sequencing Conference on May 29-31st in Boston, MA.
Richard Weinshilboum, Professor of Molecular Pharmacology & Experimental Therapeutics at the Mayo Clinic College of Medicine will be giving the keynote presentation entitled "Pharmacogenomics: Beyond Biomarkers" at the 2nd Genomic & Proteomic Drug Discovery Conference on May 29-31st, 2012 in Boston, MA by GTC.
Michael Yaffe, Professor, David H. Koch Professor of Science, Koch Institute for Integrative Cancer Biology, Depts. of Biology and Biological Engineering, and Broad Institute, Massachusetts Institute of Technology to give a Keynote Presentation on "Dynamic Re-Wiring of Signaling Networks - A Rational Approach to Optimizing Combination Therapy for Cancer".at the 7th Protein Kinases in Drug Discovery Conference (May 30-31, 2012 in Boston, MA).
Rachel Meyers, Vice President of Research and RLD at Alnylam will give a featured presentation on "RNAi Therapeutics: from Discovery to Clinical Development" at the 3rd RNAi Research and Therapeutics Conference taking place on May 30-31, 2012 in Boston, MA.
Peter T. Lomedico, Director of Industry Partnerships, Cure Therapies at Juvenile Diabetes Research Foundation [JDRF] will participate in the panel discussion called "Partnering with Non-Profits" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
Glen Prestwich, Presidential Professor, Director,Therapeutic Biomaterials Center, Special Presidential Assistant for Faculty Entrepreneurism, Department of Medicinal Chemistry at University of Utah to give a Keynote Presentation on "Clinical Biomaterials for Regenerative Medicine: From Bench to Business" at GTC's 8th Stem Cell Summit...
Tiina Palomaki, Safety Working Party & Cell Products Working Party, European Medicines Agency & Finnish Medicines Agency to give a Featured Presentation on "Regulatory Requirements for Stem Cell-based Medicinal Products in the EU" at the 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA).
Surgery also marked first time SDOCT used to image elephant.
inGenious Targeting Laboratory (iTL), a leader in the industry of genetically modified mice, announces the relocation of their world headquarters to a new facility in Ronkonkoma, NY.
CTS is one of the largest Time System integrators in North America, which is getting momentum in BC due to its highly advanced and customized electronic time clocks. Scroll down to know what's exclusive for you.
Canadian Time Systems have been offering electronic time clocks called as Amano 4700 / 4800 coming with consecutive numbering feature in Port Coquitlam, BC.
The team is knowledgeable about the products the company sells with its specifications and happy to answer all your quarries related to this.
Anne Altmeyer, Executive Director, Business Development & Licensing, Oncology, at Novartis is a Panelist in "Panel Discussion: Innovative Partnering & Licensing Strategies" at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC.
Claude Gimmi, Global Head, Business development and Licensing Oncology, Therapeutic Alliances and Strategic Partnerships at Boehringer-Ingelheim to give a Featured Presentation on "Sincerely, Yours - Partnering with Boehringer Ingelheim in Oncology" at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC.
John Herrmann, Senior Director, Global External Research & Development, Oncology at Eli Lilly to give a Featured Presentation on "Partnering with Lilly Oncology: Bring Proof-of-Relevance or Go Lean-to-POC" at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC.
November 9, 2011 - RI Technologies' (www.researchimpact.com) market insight report on Unnatural Amino Acids gives an insight into the different types of Unnatural Amino Acids (β-Amino Acids, β-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other. The study includes estimations and predictions for 2005-2015 for the global Unnatural Amino Acids market by type and applications.
Michael G. Kurilla, Director of the Office of BioDefense Research Affairs at NIAID, NIH will give a featured presentation on "Novel, Antiviral Host Based Targeting Influencing Drug Development" at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC.
Neil S. Ryder, Executive Director of Infectious Diseases at Novartis Institutes for BioMedical Research will give a featured presentation on "Opportunities and Challenges for Novel Antifungal Therapies" at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC.
Richard Hatchett, Chief Medical Officer and Deputy Director of BARDA and Joseph Larsen, Chief of the Broad Spectrum Antimicrobials (BSA) Program at BARDA will present on "Partnering and Working with BARDA" at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC.
The hearing test includes an otoscopic examination and a pure tone air conduction test to determine overall hearing ability.
Charles R. Cantor, Chief Scientific Officer at Sequenom and Member of the US National Academy of Sciences, to give a plenary keynote presentation at the 7th Modern Drug Discovery and Development Summit (Oct 19-21, 2011 in San Diego, CA).
William R. Strohl, Vice President of Biologics Research at Johnson & Johnson, will give a plenary keynote presentation on "The Future of Antibodies and Antibody-Like Protein Therapeutics" at the 7th Modern Drug Discovery and Development Summit to be held in San Diego, CA on October 19-21, 2011 by GTC.
A master's thesis in bio-informatics was successfully completed using leading Open Source LIMS Bika, thus far considered mainly for chemistry applications in agriculture, public health, environmental science and water quality management.
Dr. Philip Dormitzer, Head, Viral Advanced Programs Global Program Team, Novartis Vaccines and Diagnostics, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA).
The following is a press release that deals about M & S Ryan Plant Hire. It informs about its various services and also the new ventures it is going to take up.
The world's first book on Maria Orsic and the Ladies of Vril, and Nikola Tesla's extraterrestrials' connection. Hundreds upon hundreds of photos, drawings and sketches from the original files.
Kanta Subbarao, Chief of Emerging Respiratory Viruses Section at the National Institute of Allergy and Infectious Diseases, National Institute of Health, to deliver keynote presentation at the "9th Annual Vaccines Discovery and Development: All Things Considered" conference, to be held on Nov. 7-8, 2011 in Boston, MA by GTC.
